Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genotoxic therapy and resistance mechanism in gliomas
Fengchao Lang, Yang Liu, Fu-Ju Chou, et al.
Pharmacology & Therapeutics (2021) Vol. 228, pp. 107922-107922
Open Access | Times Cited: 80

Showing 1-25 of 80 citing articles:

Ursolic Acid Suppresses Colorectal Cancer by Down-Regulation of Wnt/β-Catenin Signaling Pathway Activity
Hui Zhao, Shun Tang, Tao Qiu, et al.
Journal of Agricultural and Food Chemistry (2023) Vol. 71, Iss. 9, pp. 3981-3993
Closed Access | Times Cited: 57
LncRNA NEAT1 facilitates glioma progression via stabilizing PGK1
Jingshan Liang, Changtao Liu, Dezhi Xu, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 52
A novel compound EPIC-0412 reverses temozolomide resistance via inhibiting DNA repair/MGMT in glioblastoma
Jixing Zhao, Shixue Yang, Xiaoteng Cui, et al.
Neuro-Oncology (2022) Vol. 25, Iss. 5, pp. 857-870
Open Access | Times Cited: 39
Single‐cell RNA sequencing reveals tumor heterogeneity, microenvironment, and drug‐resistance mechanisms of recurrent glioblastoma
Haibin Wu, Chengcheng Guo, Chaoye Wang, et al.
Cancer Science (2023) Vol. 114, Iss. 6, pp. 2609-2621
Open Access | Times Cited: 36
Quercetin induces MGMT+ glioblastoma cells apoptosis via dual inhibition of Wnt3a/β-Catenin and Akt/NF-κB signaling pathways
Wanyu Wang, Xiaopeng Yuan, Jiasheng Mu, et al.
Phytomedicine (2023) Vol. 118, pp. 154933-154933
Closed Access | Times Cited: 27
USP36 promotes tumorigenesis and drug sensitivity of glioblastoma by deubiquitinating and stabilizing ALKBH5
Guoqiang Chang, Gloria S. Xie, Li Ma, et al.
Neuro-Oncology (2022) Vol. 25, Iss. 5, pp. 841-853
Open Access | Times Cited: 30
An overview of glioblastoma multiforme and temozolomide resistance: can LC-MS-based proteomics reveal the fundamental mechanism of temozolomide resistance?
Milan Teraiya, Hélène Perreault, Vincent Chen
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 20
EPIC-0628 abrogates HOTAIR/EZH2 interaction and enhances the temozolomide efficacy via promoting ATF3 expression and inhibiting DNA damage repair in glioblastoma
Eryan Yang, Biao Hong, Yunfei Wang, et al.
Cancer Letters (2024) Vol. 588, pp. 216812-216812
Closed Access | Times Cited: 7
Brain gliomas: Diagnostic and therapeutic issues and the prospects of drug-targeted nano-delivery technology
Baoqin Song, Xiu Wang, Lijing Qin, et al.
Pharmacological Research (2024) Vol. 206, pp. 107308-107308
Open Access | Times Cited: 7
The power and the promise of synthetic lethality for clinical application in cancer treatment
Qianwen Liu, Zhiwen Yang, Qing-Hai Tang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 172, pp. 116288-116288
Open Access | Times Cited: 6
Identification of TMZ resistance‐associated histone post‐translational modifications in glioblastoma using multi‐omics data
Liguo Ye, Lingui Gu, Yaning Wang, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 3
Open Access | Times Cited: 6
Different origin-derived exosomes and their clinical advantages in cancer therapy
Xiaoyan Jin, Jing Zhang, Yufu Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Comprehensive review of drug resistance in mammalian cancer stem cells: implications for cancer therapy
Bemrew Admassu Mengistu, Tirunesh Tsegaw, Yitayew Demessie, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6
A review for the pharmacological effects of paeoniflorin in the nervous system
Hongxiang Hong, Xu Lu, Chunshuai Wu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 28
Molecular targeted therapy: A new avenue in glioblastoma treatment (Review)
Oula El Atat, Rayan Naser, Maya Abdelkhalek, et al.
Oncology Letters (2022) Vol. 25, Iss. 2
Open Access | Times Cited: 27
5-Methylcytosine Related LncRNAs Reveal Immune Characteristics, Predict Prognosis and Oncology Treatment Outcome in Lower-Grade Gliomas
Jiheng Zhang, Nan Wang, Jiasheng Wu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 23
METTL3 knockdown promotes temozolomide sensitivity of glioma stem cells via decreasing MGMT and APNG mRNA stability
Jia Shi, Peng Zhang, Xuchen Dong, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 15
Development of End-to-End AI–Based MRI Image Analysis System for Predicting IDH Mutation Status of Patients with Gliomas: Multicentric Validation
João Santinha, Vasileios K. Katsaros, George Stranjalis, et al.
Deleted Journal (2024) Vol. 37, Iss. 1, pp. 31-44
Open Access | Times Cited: 5
PARP Inhibitors and Myeloid Neoplasms: A Double-Edged Sword
Clifford M. Csizmar, Antoine N. Saliba, Elizabeth M. Swisher, et al.
Cancers (2021) Vol. 13, Iss. 24, pp. 6385-6385
Open Access | Times Cited: 31
Research progress of anti-glioma chemotherapeutic drugs (Review)
Yi-Shu Zhou, Wei Wang, Na Chen, et al.
Oncology Reports (2022) Vol. 47, Iss. 5
Open Access | Times Cited: 22
ATX-101, a Peptide Targeting PCNA, Has Antitumor Efficacy Alone or in Combination with Radiotherapy in Murine Models of Human Glioblastoma
Giovanni Luca Gravina, Alessandro Colapietro, A. Mancini, et al.
Cancers (2022) Vol. 14, Iss. 2, pp. 289-289
Open Access | Times Cited: 21
Molecular Profile as an Outcome Predictor in Glioblastoma along with MRI Features and Surgical Resection: A Scoping Review
Serban Papacocea, Daniela Vrînceanu, Mihai Dumitru, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9714-9714
Open Access | Times Cited: 4
Machine learning predicts cuproptosis-related lncRNAs and survival in glioma patients
Shaocai Hao, Maoxiang Gao, Qin Li, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Long Non-Coding RNAs in Malignant Human Brain Tumors: Driving Forces Behind Progression and Therapy
Dakun Pei, Dandan Zhang, Yan Guo, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 694-694
Open Access
Single-nucleotide-resolution genomic maps of O6-methylguanine from the glioblastoma drug temozolomide
Jasmina Büchel, Vakil Takhaveev, Cécile Mingard, et al.
Nucleic Acids Research (2025) Vol. 53, Iss. 2
Open Access
Page 1 - Next Page

Scroll to top